0001493152-26-007598
SEC filingTriSalus Life Sciences, Inc. entered into an underwriting agreement on February 19, 2026, constituting a material definitive agreement. The Company also issued a press release announcing the offering, with the underwriting agreement attached as Exhibit 1.1 and the press release as Exhibit 99.1.